CHSCN CHS Forecast, Technical & Fundamental Analysis

CHSCN in upward trend: price rose above 50-day moving average on August 31, 2026

CHSCN moved above its 50-day moving average on August 31, 2026 date and that indicates a change from a downward trend to an upward trend. In 6 of 63 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 10%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 03, 2026. You may want to consider a long position or call options on CHSCN as a result. In 6 of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 5%.

The Moving Average Convergence Divergence (MACD) for CHSCN just turned positive on September 04, 2026. Looking at past instances where CHSCN's MACD turned positive, the stock continued to rise in 4 of 49 cases over the following month. The odds of a continued upward trend are 8%.

Following a +0.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHSCN advanced for three days, in 17 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 6%.

CHSCN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 4 of 244 cases where CHSCN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 2%.

Bearish Trend Analysis

The 10-day RSI Indicator for CHSCN moved out of overbought territory on August 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 1 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 4%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 3 of 69 cases where CHSCN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 4%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHSCN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 10%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (2.890). P/E Ratio (0.000) is within average values for comparable stocks, (34.692). CHSCN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.448). CHSCN has a moderately high Dividend Yield (0.070) as compared to the industry average of (0.044). P/S Ratio (0.000) is also within normal values, averaging (2.401).

The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. CHSCN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHSCN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.